Position in IRON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,882,017
-$781,575 QoQ
Shares Held
135,111
-19.0% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 216 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in IRON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. IRON ranks #117 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IRON
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,882,017 | 135,111 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,663,592 | 166,775 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $10,798,646 | 135,986 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,651,036 | 161,184 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $8,940,811 | 168,822 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,671,027 | 53,808 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,240,870 | 35,345 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,444,319 | 70,092 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,730,744 | 60,589 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,304,400 | 213,691 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,846,009 | 31,960 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,528,603 | 53,823 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $24,779,461 | 558,096 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,830 | 2,682 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $39 | 2 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 GMTX | — | 246 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 GMTX | — | 240 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 GMTX | — | 7,141 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 GMTX | — | 20,761 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 GMTX | — | 11,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 GMTX | — | 15,398 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 GMTX | — | 3,468 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||